Comparing ARNI With ACE Inhibitor on Endothelial Function
Status:
Withdrawn
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
PARADOR is multisite, randomized, double-blind, phase IV clinical trial to compare the effect
of sacubitril/valsartan (Entresto™) to enalapril (Vasotec®) on blood vessel function in
subjects with heart failure with reduced ejection fraction (HFREF).
Phase:
Phase 4
Details
Lead Sponsor:
Brigham and Women's Hospital University of Wisconsin, Madison
Collaborators:
Brigham and Women's Hospital Novartis Pharmaceuticals